Salarius Pharmaceuticals, Inc.·4

May 5, 5:10 PM ET

Arthur David J. 4

4 · Salarius Pharmaceuticals, Inc. · Filed May 5, 2021

Insider Transaction Report

Form 4
Period: 2021-05-03
Arthur David J.
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2021-05-03$0.57/sh+9,822$5,56996,247 total
Footnotes (1)
  • [F1]The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    wf-form4_162024898808755.xmlPrimary

    FORM 4